Efficacy of probiotics administration in prevention of migraine in children: A randomized clinical trial study. probiotics administration in prevention of migraine in children
Iranian Journal of Child Neurology,
Vol. 18 No. 2 (2024),
12 March 2024
,
Page 103-112
https://doi.org/10.22037/ijcn.v17i4.39598
Abstract
Objectives
Migraine is a chronic and joint disease in children. The results of previous studies on the effectiveness of probiotics in preventing migraine attacks in children have been controversial. This study aims to investigate the effect of probiotics on migraine prophylaxis in children.
Materials & Methods
In this clinical trial study, 41 children aged 5 to 15 with migraine enrolled the study in two control and intervention groups. Children in the intervention group (18 children) received propranolol at a dose of 1 mg per kilogram of body weight daily in two divided doses along with a 250 mg Yomogi capsule daily for three months, and children in the control group (23 children), received propranolol along with placebo for three months. The study compared the frequency and duration of headache days, PedMIDAS criteria, and parental satisfaction between the two groups before treatment, as well as one month and three months post-treatment.
Results
The number of headache days in both groups decreased over time, but in the intervention group, this decrease was more than the control group was statistically significant (P=0.045). The average PedMIDAS scale after treatment in the intervention group was 3.9 ± 3.8; in the control group, it was 8.4 ± 8.2, which was statistically significant (P=0.047). Parents’ satisfaction with the treatment was statistically significantly higher in the intervention group (94.4%) than in the control group (54.5%) (P=0.011). No significant drug complications were seen in any of the two groups.
Conclusion
In children with migraine, adding probiotics to migraine treatment reduces the intensity and number of days of children’s headaches and increases the Parents’ satisfaction with the treatment
- migraine, probiotics, children
How to Cite
References
2. Jain S, Yuan H, Spare N, Silberstein SD. Erenumab in the treatment of migraine. Pain Manag. 2018 Nov 01;8(6):415-426.
3. Al Khalili Y , Chopra P .Migraine Headache In Childhood. StatPearls [Internet]. StatPearls Publishing In: Treasure Island (FL); 2021 May 4.
4. Hoover L E. Migraines in Children: Recommendations for Acute and Preventive Treatment.Am Fam Physician. 2020 May 1;101(9):569-571.
5. Abbaskhanian A, Sadeghi HR, Erfani A, Rezai MS. Effective dose of topiramate in pediatric migraine prophylaxis. J Pediatr Neurosci. 2012 Sep;7(3):171-4
6. Vikelis M, Spingos KC, Rapoport AM. A new era in headache treatment. Neurol Sci. 2018;39(Suppl 1):47-58.
7. Puledda F, Goadsby PJ. An Update on Non-Pharmacological Neuromodulation for the Acute and Preventive Treatment of Migraine. Headache. 2017;57(4):685-91.
8. Arzani M, Jahromi SR, Ghorbani Z, Vahabizad F, Martelletti P, Ghaemi A, et al. Gut-brain Axis and migraine headache: a comprehensive review. J Headache Pain. 2020;21(1):15.
9. Maqsood R, Stone TW. The gut-brain Axis, BDNF. NMDA and CNS Disorders Neurochem Res. 2016;41(11):2819–2835.
10. Greene K, Irwin SL, Gelfand AA. Pediatric Migraine: An Update. Neurol Clin. 2019;37(4):815-33.
11. Plaza-Diaz J, Ruiz-Ojeda FJ, Gil-Campos M, Gil A. Mechanisms of Action of Probiotics. Adv Nutr. 2020 Jul 1:11(4): 1054. PMID: 30721959; PMCID: PMC6363529
12. Karczewski J, Troost FJ, Konings I, Dekker J, Kleerebezem M, Brummer RJ, et al. Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am J Physiol Gastrointest Liver Physiol. 2010;298(6):G851-9.
13. Naghibi MM , Day R , Stone S , Harper A. Probiotics for the Prophylaxis of Migraine A Systematic Review of Randomized Placebo Controlled Trials. J. Clin. Med. 2019, 8, 1441; doi:10.3390
14. Parohan M, Djalali M, Sarraf P, Yaghoubi S, Seraj A, Foroushani AR, et al. Effect of probiotic supplementation on migraine prophylaxis: a systematic review and meta-analysis of randomized controlled trials. Nutr Neurosci. 2022;25(3):511-8.
15. Martami, F.; Togha, M.; Seifishahpar, M.; Ghorbani, Z.; Ansari, H.; Karimi, T.; Jahromi, S.R. The Effects of a Multispecies Probiotic Supplement on Inflammatory Markers and Episodic and Chronic Migraine Characteristics: A Randomized Double-Blind Controlled Trial. Cephalalgia 2019, 39, 841–853.
16. Hershey AD, Powers SW, Vockell AL, LeCates S, Kabbouche MA, Maynard MK. PedMIDAS: development of a questionnaire to assess disability of migraines in children. Neurology. 2001;57(11):2034-9.
17. 16. Dai YJ, Wang HY, Wang XJ, Kaye AD, Sun YH. Potential Beneficial Effects of Probiotics on Human Migraine Headache: A Literature Review. Pain Physician. 2017;20(2):E251-e5.
18. van Hemert S, Breedveld AC, Rovers JM, Vermeiden JP, Witteman BJ, Smits MG, et al. Migraine associated with gastrointestinal disorders: review of the literature and clinical implications. Front Neurol. 2014;5:241.
19. Yücel M, Kotan D, Gurol Çiftçi G, Çiftçi IH, Cikriklar HI. Serum levels of endocan, claudin-5 and cytokines in migraine. Eur Rev Med Pharmacol Sci. 2016;20(5):930-6.
20. Drummond PD. Tryptophan depletion increases nausea, headache and photophobia in migraine sufferers. Cephalalgia. 2006;26(10):1225-33.
21. Indrio F, Riezzo G, Raimondi F, Bisceglia M, Filannino A, Cavallo L, et al. Lactobacillus reuteri accelerates gastric emptying and improves regurgitation in infants. Eur J Clin Invest. 2011;41(4):417-22.
22. Wallace CJK, Milev R. The effects of probiotics on depressive symptoms in humans: a systematic review. Annals of General Psychiatry. 2017;16(1):14.
23. Desbonnet L, Garrett L, Clarke G, Bienenstock J, Dinan TG. The probiotic Bifidobacteria infantis: An assessment of potential antidepressant properties in the rat. J Psychiatr Res. 2008;43(2):164-74.
24. Sajedi D, Shabani R, Elmieh A. Changes in leptin, serotonin, and cortisol after eight weeks of aerobic exercise with probiotic intake in a cuprizone-induced demyelination mouse model of multiple sclerosis. Cytokine. 2021;144:155590.
25. Straube A, Müller H, Stiegelbauer V, Frauwallner A. [Migraine prophylaxis with a probiotic. Results of an uncontrolled observational study with 1,020 patients]. MMW Fortschr Med. 2018;160(Suppl 5):16-21.
26. Sensenig J, Johnson M, Staverosky T. Treatment of migraine with targeted nutrition focused on improved assimilation and elimination. Altern Med Rev. 2001;6(5):488-94.
27. de Roos NM, Giezenaar CG, Rovers JM, Witteman BJ, Smits MG, van Hemert S. The effects of the multispecies probiotic mixture Ecologic®Barrier on migraine: results of an open-label pilot study. Benef Microbes. 2015;6(5):641-6.
28. de Roos NM, van Hemert S, Rovers JMP, Smits MG, Witteman BJM. The effects of a multispecies probiotic on migraine and markers of intestinal permeability-results of a randomized placebo-controlled study. Eur J Clin Nutr. 2017;71(12):1455-62.
- Abstract Viewed: 546 times